Engineering Controlled Peritumoral Inflammation to Constrain Brain Tumor Growth.

Journal Article (Journal Article)

Brain tumors remain a great clinical challenge, in part due to their capacity to invade into eloquent, inoperable regions of the brain. In contrast, inflammation in the central nervous system (CNS) due to injuries activates microglia and astrocytes culminating in an astroglial scar that typically "walls-off" the injury site. Here, the hypothesis is tested that targeting peritumoral cells surrounding tumors to activate them via an inflammatory stimulus that recapitulates the sequelae of a traumatic CNS injury, could generate an environment that would wall-off and contain invasive tumors in the brain. Gold nanoparticles coated with inflammatory polypeptides to target stromal cells in close vicinity to glioblastoma (GBM) tumors, in order to activate these cells and stimulate stromal CNS inflammation, are engineered. It is reported that this approach significantly contains tumors in rodent models of GBM relative to control treatments (reduction in tumor volume by over 300% in comparison to controls), by the activation of the innate and adaptive immune response, and by triggering pathways related to cell clustering. Overall, this report outlines an approach to contain invasive tumors that can complement adjuvant interventions for invasive GBM such as radiation and chemotherapy.

Full Text

Duke Authors

Cited Authors

  • Saxena, T; Lyon, JG; Pai, SB; Pare, D; Amero, J; Karumbaiah, L; Carroll, SL; Gaupp, E; Bellamkonda, RV

Published Date

  • February 2019

Published In

Volume / Issue

  • 8 / 4

Start / End Page

  • e1801076 -

PubMed ID

  • 30537355

Pubmed Central ID

  • PMC6657526

Electronic International Standard Serial Number (EISSN)

  • 2192-2659

International Standard Serial Number (ISSN)

  • 2192-2640

Digital Object Identifier (DOI)

  • 10.1002/adhm.201801076


  • eng